Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroyasu Yoshioka is active.

Publication


Featured researches published by Hiroyasu Yoshioka.


Journal of Computer Assisted Tomography | 1990

Struma ovarii: CT and MR findings.

Fumiko Matsumoto; Hiroyasu Yoshioka; Tatsumi Hamada; Osamu Ishida; Kiichirou Noda

A case of pure struma ovarii is reported with its CT, magnetic resonance (MR), and pathologic findings. Both MR and CT revealed a complex mass composed of solid elements and multiple cysts; CT revealed calcifications not apparent on MR.


European Journal of Radiology | 1994

Comparison between conventional and spiral CT in patients with hypervascular hepatocellular carcinoma

Makoto Fujita; Chikazumi Kuroda; Toshioki Kumatani; Hiroyasu Yoshioka; Keiko Kuriyama; Etsuo Inoue; Hiroshi Kasugai; Yo Sasaki

To determine the usefulness of spiral CT in the detection of hypervascular hepatic lesions, we compared conventional contrast enhanced CT (CECT) with whole liver dynamic scanning during the artery-dominant phase by spiral CT (SDCT), using hypervascular hepatocellular carcinoma (HCC) as a model. Twenty-nine patients with 56 hypervascular nodular type HCCs detected by hepatic digital subtraction angiography were examined by both CT techniques. These nodular type HCCs were divided into three groups according to diameter: < 10 mm (n = 7), 10-20 mm (n = 17), and over 20 mm (n = 32). None of seven lesions less than 10 mm in diameter was seen by either technique. Of 17 lesions 10-20 mm in diameter, four (24%) were detected by precontrast CT plus CECT, whereas 14 (82%) were detected by precontrast CT plus SDCT. There were no lesions detected by CECT only, whereas 10 lesions were detected by SDCT only (P < 0.01 by signed test). For 32 lesions over 20 mm in diameter, there was no significant difference in detection rates between the CT techniques. Our results indicate that spiral CT is useful for the detection of relatively small hypervascular hepatic lesions such as hypervascular HCCs.


Journal of Computer Assisted Tomography | 1992

CT findings in «pseudoalveolar» sarcoidosis

Takeshi Johkoh; Junpei Ikezoe; Noriyuki Takeuchi; Nobuaki Kohno; Noriyuki Tomiyama; Masanori Akira; Hidemi Ebara; Hiroyasu Yoshioka; Takahiro Kozuka

To determine the specific high resolution CT (HRCT) features for “pseudoalveolar” sarcoidosis, we reviewed HRCT of 10 patients with pathologically proven sarcoidosis. On HRCT the lesions of pseudoalveolar sarcoidosis were shown as homogeneous or inhomogeneous opacities 1–4 cm in diameter located either along the bronchovascular bundles or in the lung periphery adjacent to the pleural surface. The margin was irregular, and numerous nodules 1–2 mm in diameter were observed in the surrounding lung. Air bronchograms were observed in 6 patients. In addition to these lesions, other CT abnormalities such as nodules, groundglass opacities, thickened bronchovascular bundles, and interlobular septa were found in all 10 cases. Good response of pseudoalveolar sarcoid lesions to administration of corticosteroid was observed in all three cases in which follow-up CT was available.


Investigative Radiology | 1993

MAGNETIC RESONANCE IMAGING-HISTOLOGIC CORRELATION OF SMALL HEPATOCELLULAR CARCINOMAS AND ADENOMATOUS HYPERPLASIAS

Etsuo Inoue; Chikazumi Kuroda; Yoshifumi Narumi; Makoto Fujita; Tsuyoshi Kadota; Keiko Kuriyama; Hiroyasu Yoshioka; Shingo Ishiguro; Yo Sasaki; Shingi Imaoka

RATIONALE AND OBJECTIVES.Hepatocellular carcinomas (HCCs) usually consist of components of different histologic grade. Using surgically resected specimens, the authors obtained high-resolution magnetic resonance (MR) images and studied the relationship between histologic grade of HCCs and MR signal intensity. METHOD.In vitro MRI was performed on 15 small (less than 20-mm diameter) HCCs and 2 patients with adenomatous hyperplasia (AH) within 1 hour of surgical resection. In these 17 lesions, 24 macroscopic nodular components corresponding to MR images were recognized pathologically. The difference in MR signal intensity was examined by using tumor/phantom (T/P) signal-intensity ratio. In addition, the correlations between signal intensity on MRI and histologic criteria for grading HCC were studied. RESULTS.On T2-weighted images, grade II HCCs had significantly greater T/P values than grade I HCCs (P < .01). There is the correlation (r = .88, P < .001) between nucleocytoplasmic (N/C) ratio and signal intensity of small HCCs and AHs on T2-weighted images. CONCLUSION.The N/C ratio is an important factor relating the signal intensity to the histologic grade of these lesions on T2-weighted images.


Computer Methods and Programs in Biomedicine | 1994

Small PACS for digital medical images - reliability and security in a clinical setting

Chikazumi Kuroda; Hiroyasu Yoshioka; Tuyoshi Kadota; Yoshifumi Narumi; Hideaki Okamoto; Toshioki Kumatani; Osamu Hiruma; Yoji Kumatani; Jiro Yoshida

Recently we introduced a small Picture Archiving Communication System (PACS) for handling CT and MRI data. Our experience with this system has been useful in identifying potential problems in a clinical setting. Since the use of PACS raises both medical and social concerns, it cannot be instituted without addressing concerns related to the reliability and security issues. Although PACS is useful in the management of medical images, there are concerns about their reliability and security in a clinical setting. Reliability encompassed image quality, timeliness of the reports, and the PACS to the Radiological Information System (RIS) interface including the retrieval of the previously obtained images. The security of the patients medical data is also essential.


Biotherapy | 1992

Clinical trials of intrasplenic arterial infusion of interleukin-2 (IS-IL-2) to patients with advanced cancer

Kiyotaka Okuno; Hiroaki Ohnishi; Kenzo Koh; Hiroshi Shindo; Hiroyasu Yoshioka; Masayuki Yasutomi

We tried a infusion of interleukin-2 (IL-2) of a relatively low dose via an intrasplenic arterial catheter connected to a chronometric infusion (IS-IL-2). Eighteen patients of colorectal cancer with metastases to the liver or lung or of unresectable hepatoma received a 24 hour continuous infusion with low dose recombinant of IL-2 (mainly 8 × 105 JRU/day) for 25–40 days. All patients tolerated this protocol of the therapy and the main toxic effects were fever and general fatigue. Such serious toxicity as previously reported by high dose IL-2 therapy was not observed. Data of hepatic and renal functions were normal. IS-IL-2 therapy induced a high incidence of eosinophilia (12/18) and thrombocythemia (12/18). Peripheral natural killer (NK) and LAK activities were augmented in all patients and total white blood cell counts were increased during IS-IL-2 therapy. An increase in IL-2 receptor expression of peripheral blood mononuclear cells and significant rises in numbers of Leull (CD16)+, OKMl(CD11)+ and OKIal(HLA-DR)+ were observed. Of 18 patients 12 were evaluable for their response to therapy. Partial response (PR) was observed in one unresectable hepatoma and 11 demonstrated no change (NC) or progressive disease (PD). Six patients were not evaluable because of additional therapy (3 cases) or decreasing tumor cell markers having no measurable lesions (3 cases). Three patients of colorectal cancer from an unresectable group were presumed to have micrometastases to the liver as suggested by an elevated serum CEA level. After receiving IS-IL-2 therapy they demonstrated a decrease in the serum CEA level for more than 3 years after treatment. We conclude that continuous IS-IL-2 administration can result in an increase of their therapeutic efficacy of IL-2 administration and in a decrease its toxicity.


Acta Radiologica | 1992

P-31 MR spectrum and histologic changes after intrahepatic arterial injection of iodized oil in normal and cirrhotic rat liver

A. Ohkusa; Hiroyasu Yoshioka; O. Ishida

Injection of iodized oil (Lipiodol) into the hepatic artery is widely used in the diagnosis and treatment of hepatocellular carcinoma. However, no reports have yet appeared concerning temporal changes in hepatic metabolism following Lipiodol injection. In the present study, Lipiodol was injected into the hepatic arteries of normal and cirrhotic rats, successive P-31 MR measurements were performed, and temporal changes in metabolism were compared with histologic findings. Both normal and cirrhotic rats displayed minimum levels of β-ATP/PME and β-ATP/Pi 5 days after hepatic arterial injection of Lipiodol. However, 10 days after injection these values had reverted to the preinjection levels. The metabolic dysfunction observed in the liver following hepatic arterial injection of 0.3 ml/kg b.w. Lipiodol was transient. Moreover, no distinct differences were observed between P-31 MR changes in normal and cirrhotic rats. Conversely, histologic impairment assessed on the basis of hepatic necrosis ratios was most severe 2 days after hepatic arterial injection in both normal and cirrhotic rats, and this did not coincide with the time of the most pronounced metabolic impairment as inferred from P-31 MR changes.


Radiation Medicine | 2000

Helical CT imaging of gastric cancer: normal wall appearance and the potential for staging.

Koichi Kadowaki; Takamichi Murakami; Hiroyasu Yoshioka; Tonsok Kim; Satoru Takahashi; Kaname Tomoda; Yoshifumi Narumi; Hironobu Nakamura


Cancer Chemotherapy and Pharmacology | 1992

Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma

Norio Nakao; Hideo Uchida; Keiji Kamino; Yukihiro Nishimura; Hajime Ohishi; Yukio Takayasu; Hironobu Nakamura; Chikazumi Kuroda; Makoto Fujita; Hiroyasu Yoshioka; Osamu Ishida


Radiation Medicine | 1992

MRI of anterior mediastinal tumors.

Junpei Ikezoe; Noriyuki Takeuchi; Takeshi Johkoh; Nobuaki Kohno; Shodayu Takashima; Noriyuki Tomiyama; Jun Arisawa; Yamagami H; Hiroyasu Yoshioka; Higashihara T

Collaboration


Dive into the Hiroyasu Yoshioka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hideo Uchida

Nara Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge